방사선종양학

본문글자크기
  • 2017년 12월호
    [Radiother Oncol.] Nodal areas of potential geographic error in adjuvant radiotherapy for biliary tract cancer.

    Military Institute of Medicine(Poland) / Lucyna Kepka*

  • 출처
    Radiother Oncol.
  • 등재일
    2017 Nov
  • 저널이슈번호
    125(2):365-373. doi: 10.1016/j.radonc.2017.09.025. Epub 2017 Oct 13.
  • 내용

    바로가기  >

    Abstract

    PURPOSE:
    To determine the areas of potential geographic error in adjuvant radiotherapy (RT) for biliary-tract cancer (BTC) by comparing pathological-surgical data on the pattern of nodal spread with the extent of elective nodal CTV used in published RT studies in this setting.

    MATERIAL/METHODS:
    A literature search was performed to select articles on: 1/adjuvant RT for BTC, that provided information on the lymph node stations (LNS) included in the CTV; 2/the pathological-surgical data on the patterns of nodal involvement/recurrence in BTC. Risk of nodal involvement/recurrence and frequency of inclusion in the CTV in RT studies for each of the LNS were compared to determine the areas of potential geographic misses and unnecessary irradiation, separately for intrahepatic cholangiocarcinoma (IHC), extrahepatic cholangiocarcinoma (EHC) and gallbladder-cancer (GBC).

    RESULTS:
    Areas of potential geographic misses include: for right IHC: paraaortic and superior mesenteric artery (SMA) LNS; for left or hilar IHC: left gastric, lesser gastric curvature, paraaortic, and SMA LNS; for proximal EHC: paraaortic LNS; for middle EHC: paraaortic and SMA LNS; for distal EHC: paraaortic, SMA, and anterior pancreatico-duodenal LNS; for GBC: paraaortic, SMA, and posterior pancreatico-duodenal LNS. Celiac-LNS is unnecessarily irradiated for middle/distal EHC.

    CONCLUSIONS:
    In view of discrepancies between pathological-surgical data and the CTVs used in common practice, there is an obvious need for international consensus guidelines.

     

     

    Author information

    Socha J1, Michalak M2, Wołąkiewicz G3, Kepka L4.
    1
    Radiation Oncology Department, Regional Oncology Center, Czestochowa, Poland; Radiation Oncology Department, Military Institute of Medicine, Warsaw, Poland.
    2
    Diagnostic Imaging Department, Independent Public Care Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Center, Olsztyn, Poland.
    3
    Radiation Oncology Department, Independent Public Care Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Center, Olsztyn, Poland.
    4
    Radiation Oncology Department, Military Institute of Medicine, Warsaw, Poland. Electronic address: lkepka@wim.mil.pl.

  • 키워드
    Socha J1, Michalak M2, Wołąkiewicz G3, Kepka L4.
  • 편집위원

    드문 종양이기는 하나 상대적으로 국내에 호발하는 담도암에서 target volume 설정 시에 참고할 만한 논문입니다.

    덧글달기2017-12-12 14:44:37

  • 덧글달기
    덧글달기
       IP : 3.144.104.29

    등록